Treace Medical Concepts, Inc. (TMCI) Free cash flow 2019–2025
Treace Medical Concepts, Inc. (TMCI) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$29.5MFY2025 · since FY2019: -$8.9M → -$29.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$29.5M | +39.5% |
| FY2024 | -$48.8M | -5.9% |
| FY2023 | -$46.0M | -1.2% |
| FY2022 | -$45.5M | -128.6% |
| FY2021 | -$19.9M | -257.7% |
| FY2020 | -$5.6M | +37.4% |
| FY2019 | -$8.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TMCI financial trends
TMCI RevenueTMCI Net incomeTMCI Net marginTMCI Gross profitTMCI Gross marginTMCI Operating incomeTMCI Operating marginTMCI Operating cash flowTMCI Capital expendituresTMCI Return on equityTMCI Stock buybacksTMCI Dividends paidTMCI Total assetsTMCI Total liabilitiesTMCI Shareholders’ equityTMCI overview →